GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,345,591 | +7.8% | 1,410,446 | +56.5% | 0.00% | 0.0% |
| Q2 2023 | $4,957,244 | +148.6% | 901,317 | +94.3% | 0.00% | – |
| Q1 2023 | $1,994,000 | +109883.5% | 463,854 | +0.6% | 0.00% | – |
| Q4 2022 | $1,813 | -99.9% | 461,140 | +0.7% | 0.00% | – |
| Q3 2022 | $2,433,000 | -42.4% | 458,075 | -28.9% | 0.00% | -100.0% |
| Q2 2022 | $4,226,000 | -12.8% | 644,256 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $4,847,000 | +21.8% | 660,275 | +17.5% | 0.00% | – |
| Q4 2021 | $3,979,000 | -91.2% | 562,005 | -68.9% | 0.00% | -100.0% |
| Q3 2021 | $45,376,000 | +15.1% | 1,809,978 | +23.5% | 0.01% | +20.0% |
| Q2 2021 | $39,437,000 | -8.4% | 1,466,092 | -3.1% | 0.01% | -16.7% |
| Q1 2021 | $43,053,000 | +94.9% | 1,512,765 | +94.2% | 0.01% | +100.0% |
| Q4 2020 | $22,086,000 | +35.6% | 779,070 | +47.9% | 0.00% | 0.0% |
| Q3 2020 | $16,284,000 | +66.1% | 526,634 | +12.8% | 0.00% | +50.0% |
| Q2 2020 | $9,806,000 | – | 466,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |